Seyhan A
Int J Mol Sci. 2024; 25(14).
PMID: 39063215
PMC: 11277426.
DOI: 10.3390/ijms25147974.
Shaik M, Sagar P, Shaik N, Randhawa N
Int J Mol Sci. 2023; 24(13).
PMID: 37445822
PMC: 10341811.
DOI: 10.3390/ijms241310644.
Saha S, Sachdev M, Mitra S
Biomicrofluidics. 2023; 17(1):011502.
PMID: 36844882
PMC: 9949901.
DOI: 10.1063/5.0135525.
Setayesh S, Hart O, Naghdloo A, Higa N, Nieva J, Lu J
NPJ Breast Cancer. 2022; 8(1):112.
PMID: 36167819
PMC: 9515081.
DOI: 10.1038/s41523-022-00480-4.
Obermayr E, Koppensteiner N, Heinzl N, Schuster E, Holzer B, Fabikan H
J Pers Med. 2021; 11(11).
PMID: 34834576
PMC: 8620949.
DOI: 10.3390/jpm11111225.
Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology - A Pilot Study.
Bark J, Kulasinghe A, Hartel G, Leo P, Warkiani M, Jeffree R
Front Oncol. 2021; 11:681130.
PMID: 34150645
PMC: 8210776.
DOI: 10.3389/fonc.2021.681130.
Circulating biomarkers in patients with glioblastoma.
Bark J, Kulasinghe A, Chua B, Day B, Punyadeera C
Br J Cancer. 2019; 122(3):295-305.
PMID: 31666668
PMC: 7000822.
DOI: 10.1038/s41416-019-0603-6.
Circulating Tumor Cells: High-Throughput Imaging of CTCs and Bioinformatic Analysis.
Keomanee-Dizon K, Shishido S, Kuhn P
Recent Results Cancer Res. 2019; 215:89-104.
PMID: 31605225
PMC: 7679175.
DOI: 10.1007/978-3-030-26439-0_5.
Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer.
Obermayr E, Agreiter C, Schuster E, Fabikan H, Weinlinger C, Baluchova K
Cells. 2019; 8(8).
PMID: 31412616
PMC: 6721820.
DOI: 10.3390/cells8080880.
The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer.
Kapeleris J, Kulasinghe A, Warkiani M, Vela I, Kenny L, OByrne K
Front Oncol. 2018; 8:311.
PMID: 30155443
PMC: 6102369.
DOI: 10.3389/fonc.2018.00311.
Integrated Genomic Medicine: A Paradigm for Rare Diseases and Beyond.
Schork N, Nazor K
Adv Genet. 2017; 97:81-113.
PMID: 28838357
PMC: 6383766.
DOI: 10.1016/bs.adgen.2017.06.001.
Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.
Carlsson A, Nair V, Luttgen M, Keu K, Horng G, Vasanawala M
J Thorac Oncol. 2014; 9(8):1111-9.
PMID: 25157764
PMC: 4145608.
DOI: 10.1097/JTO.0000000000000235.
High-efficiency rare cell identification on a high-density self-assembled cell arrangement chip.
Chen T, Wu J, Chang Y, Fu C, Wang T, Lin C
Biomicrofluidics. 2014; 8(3):036501.
PMID: 24926391
PMC: 4032428.
DOI: 10.1063/1.4874716.
Physical biology in cancer. 2. The physical biology of circulating tumor cells.
Phillips K, Kuhn P, McCarty O
Am J Physiol Cell Physiol. 2013; 306(2):C80-8.
PMID: 24133063
PMC: 3919989.
DOI: 10.1152/ajpcell.00294.2013.
Predicting therapy response in live tumor cells isolated with the flexible micro spring array device.
Gallant J, Matthew E, Cheng H, Harouaka R, Lamparella N, Kunkel M
Cell Cycle. 2013; 12(13):2132-43.
PMID: 23759587
PMC: 3737315.
DOI: 10.4161/cc.25165.
Isolation and characterization of circulating tumor cells in prostate cancer.
Diamond E, Lee G, Akhtar N, Kirby B, Giannakakou P, Tagawa S
Front Oncol. 2012; 2:131.
PMID: 23087897
PMC: 3468833.
DOI: 10.3389/fonc.2012.00131.
